UCLA research center receives $7.4M for gene therapy clinical trials
UCLA scientists will lead Phases I and II trials for X-linked chronic granulomatous disease (CGD), which is an immunodeficiency disorder. Chronic granulomatous disease is a life-threatening genetic disorder that inhibits white blood cells from ...
Daily Bruin - Tue, 28 Jul 2015 18:07



UCLA stem cell researchers receive $7.4 million to study immunodeficiency disorder
Chronic granulomatous disease, which prevents white blood cells from killing foreign invaders such as bacteria, fungi and other microorganisms, is an inherited blood disorder affecting approximately 1 in 200,000 persons in the United States. The ...
UC Los Angeles - Tue, 28 Jul 2015 09:04



Drug Maker Depomed Skeptical of Horzon Pharma's Latest Bid
Horizon Pharma, based in Dublin, makes rare-disease drugs like Actimmune, which is used to help reduce the frequency and severity of serious infections associated with chronic granulomatous disease. It reported sales of $297 million in 2014 and has ...
New York Times - Tue, 21 Jul 2015 05:18

Horizon Pharma plc Announces Collaboration With Fox Chase Cancer Center to ...
ACTIMMUNE is currently approved by the U.S. Food and Drug Administration (FDA) for use in two rare diseases. It is indicated to reduce the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD), a genetic ...
CNNMoney - Mon, 27 Jul 2015 04:03

Horizon Pharma plc Announces Collaboration With Fox Chase Cancer Center to ...
It is indicated to reduce the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD), a genetic disorder that affects the functioning of some cells of the immune system. In addition, ACTIMMUNE is indicated to ...
MarketWatch - Mon, 27 Jul 2015 04:03



LTE Hedge Fund, Up 34% Last Year, Bets Big on Cayman Beachfront
Vidara was created to buy the rights to Actimmune, a drug used to treat chronic granulomatous disease, a genetic immune disorder. LTE Partners invested in Vidara in June 2012. In March 2014, Horizon Pharma, which was then based in Deerfield, Illinois, ...
Bloomberg - Wed, 15 Jul 2015 20:56



Tumor-Fighting Drugs Take on Tuberculosis
Granulomas, or masses of tissue, can keep tuberculosis bacilli sequestered from the immune system for months or years before causing full-blown disease. The bacteria can also continue to hide within granulomas even after antibiotic treatment begins ...
NOVA Next - Wed, 22 Jul 2015 10:48



Horizon Pharma Offers to Buy Depomed for $3 Billion
Horizon Pharma, based in Dublin, makes rare-disease drugs such as Actimmune, which is used to help reduce the frequency and severity of serious infections associated with chronic granulomatous disease. It reported sales of $297 million in 2014 and has ...
New York Times - Tue, 07 Jul 2015 06:00

Horizon Pharma PLC (NASDAQ:HZNP) Makes A Bid To Takeover Depomed Inc (NASDAQ ...
FinancialsTrend - Wed, 08 Jul 2015 06:10


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014